ID
13873
Description
Study of Lanreotide in Non Metastatic Castration-resistant Prostate Cancer Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01313273
Link
https://clinicaltrials.gov/show/NCT01313273
Keywords
Versions (1)
- 3/13/16 3/13/16 -
Uploaded on
March 13, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Prostate Cancer NCT01313273
Eligibility Prostate Cancer NCT01313273
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
chemotherapy docetaxel
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0392920
- UMLS CUI [1,2]
- C0246415
Description
antiandrogen therapy
Data type
boolean
Alias
- UMLS CUI [1]
- C0279492
Description
metastasis
Data type
boolean
Alias
- UMLS CUI [1]
- C0027627
Description
concomitant treatment somatostatin analogue
Data type
boolean
Alias
- UMLS CUI [1,1]
- C1707479
- UMLS CUI [1,2]
- C0732165
Similar models
Eligibility Prostate Cancer NCT01313273
- StudyEvent: Eligibility
C1518041 (UMLS CUI [2])
C0014441 (UMLS CUI [2])
C0021073 (UMLS CUI [3])
C0246415 (UMLS CUI [1,2])
C0732165 (UMLS CUI [1,2])